Back to the free edition

Paid edition · Amazon Kindle + paperback

State of Nootropics 2026: Full Edition

The annual report at full depth. 12 chapters, ~18,000 words. The free edition’s 8 chapters plus 4 additional: substance deep dives, protocol design, self-tracking methodology, and the five-year forward look.

Kindle ebook

$9.99

Reflowable EPUB. Available on every Kindle device, the Kindle app on iOS / Android / desktop, and Kindle Unlimited.

Buy on Amazon

Paperback

$14.99

6×9 in., single-column, printed on demand via Amazon KDP. Ships globally.

Buy paperback

Amazon links carry our Associates tag (nootropics.com-20) — purchases support the editorial work that produced this report.

What’s in the full edition

All 8 chapters of the free public edition — covering the state of the field, the substances people actually take, stack patterns, sleep, the longevity-cognition convergence, the grey market, AI advisor patterns, and what we got wrong in 2025 — plus the four full-edition chapters below:

  • Chapter 9 — Substance deep dives

    Eight substances treated at the depth a structured reference entry can't accommodate. Caffeine, L-Theanine, Modafinil, Lion's Mane, Bacopa, Creatine, Ashwagandha, and NR — each with the mechanism, the 2026 evidence picture, the honest read of where marketing has overshot, and a five-year forecast.

  • Chapter 10 — Protocol design 101

    The principles that separate a designed protocol from an accumulated stack. Choosing one goal, matching protocol to goal, the one-substance-at-a-time discipline, dose titration, cycling, defining failure criteria in advance, and the quarterly subtraction review.

  • Chapter 11 — Tracking your own response

    The four-metric daily tracking method that produces interpretable self-experimentation data. What to track, when, how to look at the data, and what to honestly expect from the analysis.

  • Chapter 12 — The next five years

    Three forecasts. Continued regulatory tightening on supplement-channel availability. The longevity-cognition merge producing its first widely-validated compound. AI-driven personalized protocol design becoming the dominant consumer interface — with explicit comment on what we will and won't build into our own tools.

Why pay for this

The free edition exists because the field needed a non-vendor, non-influencer, well-sourced annual synthesis. The full edition exists because the report’s editorial work — the substance research, the protocol design discipline, the tracking methodology — takes thousands of hours per year and the affiliate-and-advertising business model alone does not support it.

Paying for the full edition is the most direct way to support the work that produces both editions. It also gets you a real book — substance-level depth across the eight deep-dive subjects, the protocol design chapter that condenses years of editorial practice into one workable framework, and the tracking methodology chapter that has, in our experience, been the highest-leverage single piece of advice in personal cognitive enhancement.

  • All 12 chapters, ~18,000 words
  • Substance-by-substance deep dives on 8 foundation compounds
  • Protocol design framework + 4-metric tracking methodology
  • Forward look at regulatory, longevity-cognition, and AI-driven personalization
  • Available in Kindle reflowable + 6×9 paperback
  • Free upgrades to errata across the year; 2027 edition sold separately

Prefer the free edition?

The 8-chapter free public edition is at nootropics.com/state-of-nootropics-2026. CC BY 4.0 — share, cite, quote freely.

Go to the free edition

The State of Nootropics 2026 Full Edition is an editorial publication. The substances and protocols discussed are not medical advice. Individual response varies; pregnancy, lactation, prescription medications, and pre-existing conditions all change the calculus. Coordinate any new protocol with a qualified clinician. See our full disclaimer and terms.